3 Oct 2022

API Product Portflio

PDF 562 kB

We are a leading business-to-business provider of generic APIs. We help to secure patient safety, by driving Quality to the next level. Our reputation for producing high-quality generic APIs is well-known throughout the industry. Additionally, our business-to-business customers using our enzymatically produced APIs enjoy the freedom to operate, as these technologies are protected by patents.

Content provided by our supplier

Centrient Pharmaceuticals

  • NL
  • 2015
    On CPHI since
  • 3
  • 1000 - 4999
Company types
Primary activities
Finished Formulation products Distributor/Buyer
Generic APIs producer

Other Content from Centrient Pharmaceuticals (7)